Clinical, neurophysiological, and magnetic resonance imaging correlations in multiple sclerosis

G. Comi, M. Filippi, M. Rovaris, L. Leocani, S. Medaglini, T. Locatelli

Research output: Contribution to journalArticle

Abstract

Magnetic resonance imaging (MRI) has a pivotal role in diagnosis of multiple sclerosis and is being increasingly used as a paraclinical measure to assess treatment efficacy in clinical trials. However, the correlations between clinical and MRI findings in patients with multiple sclerosis are weak and, therefore, newer MR techniques are being developed to increase both MRI sensitivity for detecting disease activity and its pathological specificity for better assessing disease evolution. Evoked potentials (EPs) can be used to confirm the diagnosis of multiple sclerosis and their abnormalities are correlated with symptoms and signs referable to involvement of the corresponding nervous pathways. However, their use is limited when assessing disease progression and monitoring clinical trials in multiple sclerosis. Both magnetic resonance imaging (MRI) and evoked potentials (EPs) provide information which cannot be obtained by clinical evaluation, especially for assessing disease Nevertheless, both these techniques cannot substitute for clinical measures of disability when assessing disease progression and monitoring phase III clinical trials in multiple sclerosis.

Original languageEnglish
JournalJournal of Neurology, Neurosurgery and Psychiatry
Volume64
Issue numberSUPPL. 1
Publication statusPublished - May 1998

Fingerprint

Multiple Sclerosis
Magnetic Resonance Imaging
Evoked Potentials
Disease Progression
Clinical Trials
Phase III Clinical Trials
Signs and Symptoms

Keywords

  • Disability
  • Evoked potentials
  • Magnetic resonance imaging
  • Multiple sclerosis

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology
  • Neuroscience(all)
  • Psychiatry and Mental health

Cite this

@article{176d799dacf8481aa2988a4015932afa,
title = "Clinical, neurophysiological, and magnetic resonance imaging correlations in multiple sclerosis",
abstract = "Magnetic resonance imaging (MRI) has a pivotal role in diagnosis of multiple sclerosis and is being increasingly used as a paraclinical measure to assess treatment efficacy in clinical trials. However, the correlations between clinical and MRI findings in patients with multiple sclerosis are weak and, therefore, newer MR techniques are being developed to increase both MRI sensitivity for detecting disease activity and its pathological specificity for better assessing disease evolution. Evoked potentials (EPs) can be used to confirm the diagnosis of multiple sclerosis and their abnormalities are correlated with symptoms and signs referable to involvement of the corresponding nervous pathways. However, their use is limited when assessing disease progression and monitoring clinical trials in multiple sclerosis. Both magnetic resonance imaging (MRI) and evoked potentials (EPs) provide information which cannot be obtained by clinical evaluation, especially for assessing disease Nevertheless, both these techniques cannot substitute for clinical measures of disability when assessing disease progression and monitoring phase III clinical trials in multiple sclerosis.",
keywords = "Disability, Evoked potentials, Magnetic resonance imaging, Multiple sclerosis",
author = "G. Comi and M. Filippi and M. Rovaris and L. Leocani and S. Medaglini and T. Locatelli",
year = "1998",
month = "5",
language = "English",
volume = "64",
journal = "Journal of Neurology, Neurosurgery and Psychiatry",
issn = "0022-3050",
publisher = "BMJ Publishing Group",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Clinical, neurophysiological, and magnetic resonance imaging correlations in multiple sclerosis

AU - Comi, G.

AU - Filippi, M.

AU - Rovaris, M.

AU - Leocani, L.

AU - Medaglini, S.

AU - Locatelli, T.

PY - 1998/5

Y1 - 1998/5

N2 - Magnetic resonance imaging (MRI) has a pivotal role in diagnosis of multiple sclerosis and is being increasingly used as a paraclinical measure to assess treatment efficacy in clinical trials. However, the correlations between clinical and MRI findings in patients with multiple sclerosis are weak and, therefore, newer MR techniques are being developed to increase both MRI sensitivity for detecting disease activity and its pathological specificity for better assessing disease evolution. Evoked potentials (EPs) can be used to confirm the diagnosis of multiple sclerosis and their abnormalities are correlated with symptoms and signs referable to involvement of the corresponding nervous pathways. However, their use is limited when assessing disease progression and monitoring clinical trials in multiple sclerosis. Both magnetic resonance imaging (MRI) and evoked potentials (EPs) provide information which cannot be obtained by clinical evaluation, especially for assessing disease Nevertheless, both these techniques cannot substitute for clinical measures of disability when assessing disease progression and monitoring phase III clinical trials in multiple sclerosis.

AB - Magnetic resonance imaging (MRI) has a pivotal role in diagnosis of multiple sclerosis and is being increasingly used as a paraclinical measure to assess treatment efficacy in clinical trials. However, the correlations between clinical and MRI findings in patients with multiple sclerosis are weak and, therefore, newer MR techniques are being developed to increase both MRI sensitivity for detecting disease activity and its pathological specificity for better assessing disease evolution. Evoked potentials (EPs) can be used to confirm the diagnosis of multiple sclerosis and their abnormalities are correlated with symptoms and signs referable to involvement of the corresponding nervous pathways. However, their use is limited when assessing disease progression and monitoring clinical trials in multiple sclerosis. Both magnetic resonance imaging (MRI) and evoked potentials (EPs) provide information which cannot be obtained by clinical evaluation, especially for assessing disease Nevertheless, both these techniques cannot substitute for clinical measures of disability when assessing disease progression and monitoring phase III clinical trials in multiple sclerosis.

KW - Disability

KW - Evoked potentials

KW - Magnetic resonance imaging

KW - Multiple sclerosis

UR - http://www.scopus.com/inward/record.url?scp=0031778908&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031778908&partnerID=8YFLogxK

M3 - Article

C2 - 9647280

AN - SCOPUS:0031778908

VL - 64

JO - Journal of Neurology, Neurosurgery and Psychiatry

JF - Journal of Neurology, Neurosurgery and Psychiatry

SN - 0022-3050

IS - SUPPL. 1

ER -